Clinical Trial Details
EORTC-30864
Back to Clinical Trials Database
Phase II chemoresection study of mitomycin C with a marker lesion followed by a phase III study randomizing between maintenance and no maintenance in multiple TaT1 bladder cancer
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 15-Oct-1986 Date Step1 close: 15-Apr-1989 Date Step2 close: 15-Jan-1990 |
| Data management at EORTC | Yes |
| Design |
Phase 3 Randomized open label |
| Targeted Sample size | EORTC Groups: 254 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/ |
| NCT number |
